Xencor | Ativos



Assets Alterar Data
AbbVie USD 136.17B 1B 2025-03
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Amgen USD 89.37B 2.47B 2025-03
Arrowhead Research USD 1.57B 559.8M 2025-03
AstraZeneca USD 112.42B 6.17B 2025-06
Biogen USD 28.33B 297.1M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Cytokinetics USD 1.26B 137.62M 2025-03
GlaxoSmithKline GBP 59.26B 1.45B 2025-06
J&J USD 193.67B 13.57B 2025-03
MacroGenics USD 261.65M 2.84M 2024-12
Merck USD 115.12B 1.98B 2025-03
Novartis USD 104.4B 4.45B 2025-06
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Roche Holding CHF 101.8B 6.02B 2024-12
Xencor USD 904.69M 47.26M 2025-03


Xencor Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.